Anti-Cancer Drugs Issues Research Articles in March 2024 Edition
March 20, 2024
March 20, 2024
LONDON, England, March 20 -- Anti-Cancer Drugs, a journal that says it reports clinical and experimental results related to anti-cancer drugs and welcomes contributions on anti-cancer drug design, drug delivery, pharmacology, hormonal and biological modalities and chemotherapy evaluation, published research articles on the following topics in its March 2024 edition (Vol. 35, Issue 3):
Pre-Clinical Reports:
* Dual targeting of Mcl-1 and Bcl-2 to overcome chemoresistance . . .
Pre-Clinical Reports:
* Dual targeting of Mcl-1 and Bcl-2 to overcome chemoresistance . . .